Quantitative structure-cytotoxicity relationship of oleoylamides

Anticancer Research

Volumn 35, Issue 10, 2015, Pages 5341-5355

  Sakagami, Hiroshi ^a   Uesawa, Yoshihiro ^b   Ishihara, Mariko ^a   Kagaya, Hajime ^b   Kanamoto, Taisei ^c   Terakubo, Shigemi ^c   Nakashima, Hideki ^c   Takao, Koichi ^d   Sugita, Yoshiaki ^d  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d JOSAI UNIVERSITY   (Japan)

Author keywords

Anti HIV activity; Cytotoxicity; Oleoylamides; QSAR analysis; Tumor selectivity

Indexed keywords

AMIDE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTINEOPLASTIC AGENT; CATECHOL; CURDLAN; DEXTRAN SULFATE; DOXORUBICIN; FLUOROURACIL; N (1 OXO 9 OCTADECENYL)GLYCINE; N (2 HYDROXYETHYL) 9 OCTADECENAMIDE; N (4 AMINOBUTYL) 9 OCTADECENAMIDE; N (91 OXOOCTADECEN 9 YL)HISTIDINE; N (91 OXOOCTADECEN 9 YL)HISTIDINE METHYLESTER; N [2 (1 METHYL 1H IMIDAZOL 4 YL)ETHYL] 9 OCTADECENAMIDE; N [2 (1H IMIDAZOL 4 YL)ETHYL] 9 OCTADECENAMIDE; N [2 (2 BENZIMIDAZOYL)ETHYL] 9 OCTADECENAMIDE; N [2 (2 PYRIDYL)ETHYL] 9 OCTADECENAMIDE; N [2 (3,4 DIHYDROXYPHENYL)ETHYL]ETHYL] 9 OCTADECENAMIDE; N [2 (4 HYDROXY 3 METHOXYPHENYL)METHYL] 9 OCTADECENAMIDE; N [2 (4 HYDROXYPHENYL)ETHYL] 9 OCTADECENAMIDE; N [2 (5 HYDROXY 1H INDOL 3YL)ETHYL] 9 OCTADECENAMIDE; N [2 HYDROXY 1 (1H IMIDAZOL 4 YLMETHYL)ETHYL] 9 OCTADECENAMIDE; N [2 PHENYLETHYL] 9 OCTADECENAMIDE; N [3 [[4 [(3 AMINOPROPYL)AMINO]BUTYL]AMINO]PROPYL] 9 OCTADECENAMIDE; N [4 (2 PYRIDYL)AMINOBUTYL] 9 OCTADECENAMIDE; OLEIC ACID; OLEOYLAMIDE DERIVATIVE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE; OLEYLAMIDE;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CC50; CELL PROTECTION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SELECTIVITY; EC50; EPITHELIUM CELL; HUMAN; HUMAN CELL; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTUM CHEMISTRY; SQUAMOUS CELL CARCINOMA CELL LINE; CELL LINE; CHEMICAL STRUCTURE; DRUG EFFECTS; SYNTHESIS;

ANTI-HIV AGENTS; ANTINEOPLASTIC AGENTS; CELL LINE; HUMANS; MOLECULAR STRUCTURE; OLEIC ACIDS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84942744053     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ezzili C, Otrubova K and Boger DL: Fatty acid amide signaling molecules. Bioorg Med Chem Lett 20(20): 5959-5968, 2010.
2. Cravatt BF, Prospero-Garcia O, Siuzdak G, Gilula NB, Henriksen SJ, Boger DL and Lerner RA: Chemical characterization of a family of brain lipids that induce sleep. Science 268(5216): 1506-1509, 1995.
3. Huitrón-Reséndiz S, Gombart L, Cravatt BF and Henriksen SJ: Effect of oleamide on sleep and its relationship to blood pressure, body temperature, and locomotor activity in rats. Exp Neurol 172(1): 235-243, 2001.
4. Mechoulam R, Fride E, Hanus L, Sheskin T, Bisogno T, Di Marzo V, Bayewitch M and Vogel Z: Anandamide may mediate sleep induction. Nature 389(6646): 25-26, 1997.
5. Fedorova I, Hashimoto A, Fecik RA, Hedrick MP, Hanus LO, Boger DL, Rice KC and Basile AS: Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems. J Pharmacol Exp Ther 299(1): 332-342, 2001.
6. Uchiyama N, Kikura-Hanajiri R, Ogata J and Goda Y: Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Science International 198(1-3): 31-38, 2010.
7. McDonald GR, Hudson AL, Dunn SM, You H, Baker GB, Whittal RM, Martin JW, Jha A, Edmondson DE and Holt A: Bioactive contaminants leach from disposable laboratory plastic ware. Science 322(5903): 917, 2008.
8. Andreiuk GM, Kisel' MA and Litvinko NM. Effects of fatty acid amides on phosphatidylcholine hydrolysis catalyzed by phospholipase A2 in micelles. Ukr Biokhim Zh 69(1): 32-36, 1978 (in Russian).
9. Dang HT, Kang GJ , Yoo ES, Hong J, Choi JS, Kim HS, Chung HY and Jung JH: Evaluation of endogenous fatty acid amides and their synthetic analogues as potential anti-inflammatory leads. Bioorg Med Chem19(4): 1520-1527, 2011.
10. Akimov MG, Gretskaya NM, Zinchenko GN and Bezuglov VV: Cytotoxicity of endogenous lipids N-acyl dopamines and their possible metabolic derivatives for human cancer cell lines of different histological origin. Anticancer Res 35(5): 2657-2661, 2015.
11. Slätis K, Djureinovic T, Helleday T and Hunt MC: N-Acyl taurines are anti-proliferative in prostate cancer cells. Lipids 47(4): 355-361, 2012.
12. Zorko M, Majerle A, Sarlah D, Keber MM, Mohar B and Jerala R: Combination of antimicrobial and endotoxin-neutralizing activities of novel oleoylamines. Antimicrob Agents Chemother 49(6): 2307-2313, 2005.
13. Suzuki R, Matsuo S, Sakagami H, Okada Y and Shirataki Y: Search of new cytotoxic crude materials against human oral squamous cell carcinoma using 1H NMR-based metabolomics. Anticancer Res 34: 4117-4120, 2014.
14. Nakashima H, Murakami T, Yamamoto N, Sakagami H, Tanuma S, Hatano T, Yoshida T and Okuda T: Inhibition of human immunodeficiency viral replication by tannins and related compounds. Antiviral Res 18: 91-103, 1992.
15. Takao K, Noguchi K, Hashimoto Y, Shirahata A and Sugita Y: Synthesis and evaluation of fatty acid amides on the Noleoylethanolamide-like activation of peroxisome proliferator activated receptor α. Chem Pharm Bull 63: 278-285, 2015.
16. Kantoh K, Ono M, Nakamura Y, Nakamura Y, Hashimoto K, Sakagami H and Wakabayashi H: Hormetic and anti-radiation effects of tropolone-related compounds. In Vivo 24: 843-852, 2010.
17. Das S, Das U, Sakagami H, Umemura N, Iwamato S, Matsuta T, Kawase M, Molnar J, Serly J, Gorecki DKJ and Dimmock JR: Dimeric 3,5-bis(benzylidene)-4-piperidones: A novel cluster of tumour-selective cytotoxins possessing multidrug-resistant properties. Eur J Med Chem 51: 193-199, 2012.
18. Ohno H, Araho D, Uesawa Y, Kagaya H, Ishihara M, Sakagami H and Yamamoto M: Evaluation of cytotoxicity and tumor specificity of licorice flavonoids based on chemical structures. Anticancer Res 33: 3061-3068, 2013.
19. Labute P: LowModeMD-implicit low-mode velocity filtering applied to conformational search of macrocycles and protein loops. J Chem Inf Model 50: 792-800, 2010.
20. Wildman SA and Crippen GM: Prediction of physiochemical parameters by atomic contributions. J Chem Inf Comput Sci 39(5): 868-873, 1999.
21. Pearlman RS and Smith KM: Novel software tools for chemical diversity; Persp Drug Disc Des 9/10/11 (1998) 339-353, 1998. Kluwer Academic Publishers, Dordrecht, the Netherlands.
22. Stewart JJP: MOPAC Manual (Seventh Edition); 1993. Drug Design Laboratory, University of Milan, Milano, Italy.
23. Hall LH and Kier LB: The molecular connectivity chi indices and kappa shape indices in structure-property modeling. Reviews of Computational Chemistry 2 , 1991.
24. Cruciani G, Crivori P, Carrupt PA and Testa B: Molecular fields in quantitative structure-permeation relationships: the VolSurf approach. J Mol Struct 503: 17-30, 2000.
25. Petitjean M: Applications of the radius-diameter diagram to the classification of topological and geometrical shapes of chemical compounds. J Chem Inf Comput Sci 32: 331-337, 1992.
26. Chu CJ, Huang SM , De Petrocellis L, Bisogno T, Ewing SA, Miller JD , Zipkin RE , Daddario N, Appendino G , Di Marzo V and Walker JM: N-Oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J Biol Chem 278(16): 13633-13639, 2003.